Business Context and Reporting Period
Company: Community Health Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 3, 2018
Event: Entry into a Material Definitive Agreement (Asset-Based Loan Credit Agreement) and Termination of a Prior Agreement.
Key Financial Metrics and Debt Structure
This filing details a restructuring of the Company's revolving credit facilities rather than reporting operational financial results (revenue, profit, or cash flow).
- New ABL Facility: $1,000,000,000 maximum aggregate principal amount (subject to borrowing base capacity).
- Letters of Credit: $50,000,000 capacity included within the new facility.
- Previous Revolving Facility: Reduced to $425,000,000 upon effectiveness of the new agreement.
- Interest Rates (Post-Q2):
- Base Rate: 1.25%, 1.50%, or 1.75% margin.
- LIBOR Rate: 2.25%, 2.50%, or 2.75% margin.
- Commitment Fees (Post-Q1): 0.50% or 0.625% on the unused portion.
- Maturity Date: April 3, 2023 (5-year term).
- Collateral: First-priority security interest in accounts receivable and related assets; junior-priority interest in other assets.
Material Changes Versus Prior Period
- Facility Replacement: The Company entered into a new $1 billion ABL Credit Agreement with JPMorgan Chase Bank, N.A., replacing the previous revolving credit commitments.
- Capacity Reduction: The prior Credit Agreement (originally dated July 25, 2007, with multiple amendments) was reduced from its previous capacity to $425,000,000.
- Termination of Receivables Facility: The Company repaid in full and terminated its asset-backed securitization (Receivables Facility) dated March 21, 2012.
- Springing Maturity: A 91-day springing maturity clause was added, triggered if more than $250 million in specific senior notes or term loans mature prior to April 3, 2023.
Guidance, Risks, and Contingencies
Management Commentary: The filing focuses on the mechanics of the new credit agreement and does not provide operational guidance or outlook.
Risks and Covenants:
- Covenants: The ABL facility includes standard negative and affirmative covenants, events of default, and repayment provisions.
- Guarantees: The Company and all domestic subsidiaries guaranteeing other outstanding senior indebtedness will guarantee the ABL obligations.
- Refinancing Risk: The springing maturity provision creates a contingency where the facility could become due sooner if significant portions of the Company's existing debt (including 8% senior notes due 2019, Term G loans, and others) are refinanced or mature early.
Investor Verification Checklist
- Verify the current "borrowing base capacity" to determine the actual available liquidity under the $1 billion facility.
- Confirm the status of the terminated Receivables Facility to ensure no residual obligations remain.
- Monitor the Company's existing debt maturities (specifically the 2019-2023 notes and term loans) to assess the risk of triggering the 91-day springing maturity clause.
- Review the full text of the ABL Credit Agreement (Exhibit 10.1) for specific negative covenants that may restrict future operations or capital expenditures.